Brain artery block shows promise for stopping migraines

NCT ID NCT06735833

Recruiting now Disease control Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests whether blocking a small artery in the brain (the middle meningeal artery) with a special glue can prevent chronic migraines. About 70 adults with hard-to-treat chronic migraine will receive the procedure. The main goal is to see if it safely reduces the number of migraine days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIGRAINE MIGRAINE DISORDERS

Contacts and locations

Locations

Barrow Neurological Institute at St. Joseph's Hospital
WITHDRAWN

Phoenix, Arizona, 85013, United States
Hartford Hospital
RECRUITING

Hartford, Connecticut, 06032, United States
John Muir Physician Network Clin. Research Center
NOT_YET_RECRUITING

Walnut Creek, California, 94598, United States
Mount Sinai
RECRUITING

New York, New York, 10029, United States
Semmes Murphey Foundation
RECRUITING

Memphis, Tennessee, 38120, United States
Stony Brook University Medical Center
RECRUITING

Stony Brook, New York, 11794, United States
Thomas Jefferson University Hospital
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
University of Buffalo Medical Center
NOT_YET_RECRUITING

Buffalo, New York, 14203, United States
West Virginia University
RECRUITING

Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.